Impact of the hypoxic phenotype on the uptake and efflux of nanoparticles by human breast cancer cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-30517-3.pdf
Reference70 articles.
1. Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17, 20–37 (2016).
2. Duncan, R. & Gaspar, R. Nanomedicine(s) under theMicroscope. Mol. Pharmaceutics 8, 2101–2141 (2011).
3. Duncan, R. & Richardson, S. C. W. Endocytosis and Intracellular Trafficking as Gateways for Nanomedicine Delivery: Opportunities and Challenges. Mol. Pharmaceutics 9, 2380–2402 (2012).
4. Venditto, V. J. & Szoka, F. C. Jr. Cancer nanomedicines: So many papers and so few drugs! Adv. Drug Deli. Rev. 65, 80–88, https://doi.org/10.1016/j.addr.2012.09.038 (2013).
5. Palumbo, R. et al. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Drug Des. Devel. Ther. 9, 2189–2199, https://doi.org/10.2147/DDDT.S79563 (2015).
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tailoring polymeric nanocarriers for hypoxia-specific drug release: Insights into design and applications in clinics;Chemical Engineering Journal;2024-09
2. Internalization study of nanosized zeolite crystals in human glioblastoma cells;Colloids and Surfaces B: Biointerfaces;2022-10
3. Spatial Transcriptomics‐Based Identification of Molecular Markers for Nanomedicine Distribution in Tumor Tissue;Small Methods;2022-09-30
4. A novel and easy to prepare azo-based bioreductive linker and its application in hypoxia-sensitive cationic liposomal doxorubicin: Synthesis, characterization, in vitro and in vivo studies in mice bearing C26 tumor;Chemistry and Physics of Lipids;2022-09
5. Surface modifications of gold nanoparticles: stabilization and recent applications in cancer therapy;Pharmaceutical Development and Technology;2022-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3